Medical innovations in healthcare today move beyond disease treatment to revolutionize treatment delivery methods. The injectable drug delivery devices market leads healthcare delivery transformation ...

Carnegie Mellon University researchers create the first entirely collagen-based microphysiologic system with FRESH bioprinting.

The IV pole market is anticipated to be worth USD 256.5 million in 2024. The market is expected to grow at a CAGR of 3.5% ...

Using a newly devised, three-dimensional model to study the regeneration of nerve tissue in the nose, researchers at School ...

Discover how 3D biology, automation, and AI are revolutionizing drug discovery, improving predictive accuracy, and ...

There are more than 100,000 people on organ transplant lists in the U.S., some of whom will wait years to receive one—and ...

A cloud-based digital twin simulation, coupled with automated insulin delivery, allows patients with diabetes to experiment ...

Artificial organ transplants have been held back by the difficulty of making networks of blood vessels - a problem scientists ...

BACKGROUND: Cardiac hypertrophy, as an important pathological change, contributes to heart failure. Recent studies indicate ...

Market is poised for substantial growth, projected to increase from over USD 19.8 billion in 2025 to an estimated USD 37.9 ...

Adults with chronic kidney disease and type 2 diabetes had slower kidney function decline with a combination of the nonsteroidal mineralocorticoid receptor antagonist finerenone and empagliflozin vs.

New research published in the Journal of Applied Physiology suggests that erythritol, a popular sugar substitute, may ...